Future of Health Care
On this edition of Conversations LIVE our experts will talk about the consolidation of health care providers and insurers, the possibility of a shortage of doctors, and new employer wellness practices.
The November 5 election is fast approaching, and Pennsylvania is a battleground state. We’ll talk with two experts about Pennsylvania’s role as a swing state, what we can and can’t learn from polls, the race for U.S. Senate, and which issues are important to voters, and we take viewer calls.
Berwood Yost
Berwood Yost is the Director of the Center for Opinion Research and the Director of the Floyd Institute for Public Policy at Franklin & Marshall College. He is also the Director of the Franklin & Marshall College Poll, which tracks public attitudes toward public policy issues and political campaigns. His scholarship is multidisciplinary and has appeared in journals that include the fields of criminology, human rights, political science, psychology, and public health.
Dennis Plane, Ph.D.
Dennis Plane became a member of the Juniata College faculty as assistant professor of politics in 2004. He earned a bachelor’s degree in political science in 1993 from Rollins College in Winter Park, Fla., and went on to earn a doctoral degree in political behavior and American political institutions in 2002 from the University of Texas in Austin, Texas. He has taught courses in U.S. government, state and local government, public policy, Congress and public opinion. He also can teach courses on public opinion, politics and the media, campaigns and elections, minority politics and research methods.
On this edition of Conversations LIVE our experts will talk about the consolidation of health care providers and insurers, the possibility of a shortage of doctors, and new employer wellness practices.
We explore the human impact of the opioid epidemic by talking to guests who have been personally affected by addiction. We’ll also talk about Pennsylvania’s $20 million effort to address it.
Prostate cancer is one of the two most common cancers among men– one in seven males will be diagnosed within their lifetime. Despite its prevalence, treatment options vary widely based on the particulars of each case. How do you know what’s right for you?